MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Clinical trials for MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM trials appear
Sign up with your email to follow new studies for MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Drug-Radiation combo tested for Tough-to-Treat gynecologic cancers
Disease control Recruiting nowThis early-stage study is testing a new combination treatment for gynecologic cancers that have returned after previous therapy. Researchers are combining an oral drug called talazoparib with standard radiation therapy to see if it works better together. The main goal is to find …
Matched conditions: MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Major trial uses genetic blueprint to find the right drug combo for advanced cancer
Disease control Recruiting nowThis trial is a large screening program that matches patients with advanced solid tumors to one of many smaller treatment studies. It uses genetic testing on a patient's tumor to find specific mutations. Patients are then assigned to a drug combination designed to target those mu…
Matched conditions: MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New drug combo aims to outsmart tough cancers
Disease control Recruiting nowThis study is for people with advanced HER2-positive cancers that have come back or spread. It aims to see if taking two targeted drugs together works better than taking one alone to slow or stop cancer growth. About 70 participants will be randomly assigned to one of the two tre…
Matched conditions: MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New hope for easing painful side effects after cancer radiation
Symptom relief Recruiting nowThis study is testing whether a vaginal hormone treatment called DHEA can help improve vaginal health and reduce discomfort for women who have had radiation therapy for certain gynecologic or gastrointestinal cancers. Radiation can cause symptoms like vaginal dryness, pain during…
Matched conditions: MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Phase: PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Symptom relief
Last updated Apr 01, 2026 14:42 UTC
-
Can Phone-Based breathing exercises ease Post-Surgery pain?
Symptom relief Recruiting nowThis study is testing two different phone-delivered support programs to see which one better helps women recover after abdominal surgery for suspected gynecologic cancer. It will compare a mindful movement and breathing program against a life reflection program. The goal is to se…
Matched conditions: MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Phase: PHASE3 • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Mar 31, 2026 12:11 UTC
-
Seaweed vs. chemo fatigue: can a natural supplement help?
Symptom relief Recruiting nowThis study is testing whether a dietary supplement called fucoidan, derived from brown seaweed, can help prevent or reduce the severe fatigue that often comes with chemotherapy. It will involve 34 adults with gastrointestinal or gynecological cancers who are starting a specific t…
Matched conditions: MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Mar 24, 2026 12:02 UTC
-
Can zoom workouts ease the lingering pain and fatigue after cancer?
Symptom relief Recruiting nowThis small pilot study is testing whether a personalized, home-based exercise program delivered online can help reduce common and difficult symptoms like fatigue, pain, sleep problems, and depression in women who have finished treatment for gynecologic cancers. Researchers will e…
Matched conditions: MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Mar 24, 2026 12:01 UTC
-
Cancer surgery pain relief: spinal shot vs. IV medication
Symptom relief Recruiting nowThis study compares two different approaches to managing pain after surgery for gynecologic cancers. Researchers want to see if methadone given through an IV works as well as hydromorphone given as a spinal injection. The trial involves 140 patients undergoing abdominal surgery a…
Matched conditions: MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Mar 23, 2026 15:29 UTC
-
Tracking Frailty's impact on cancer recovery
Knowledge-focused Recruiting nowThis study aims to understand how being frail—more vulnerable to health stressors—affects the recovery and quality of life of people with gynecologic cancers like ovarian or uterine cancer. Researchers will observe 500 newly diagnosed patients for one year to see if frailty is li…
Matched conditions: MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:02 UTC
-
Mapping Cancer's genetic blueprint across communities
Knowledge-focused Recruiting nowThis study aims to understand how cancer-related genetic mutations differ among various ethnic populations. Researchers will collect blood or saliva samples from 1,800 cancer patients from diverse backgrounds to identify genetic patterns. The findings could help create more perso…
Matched conditions: MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Mar 18, 2026 14:40 UTC
-
Researchers probe why some surgeons skip lifesaving blood clot meds after cancer surgery
Knowledge-focused Recruiting nowThis study aims to understand how surgeons currently prevent dangerous blood clots in patients after major cancer surgery. It will survey and interview 500 surgeons and their teams across the U.S. to learn about their practices, identify barriers to following best-practice guidel…
Matched conditions: MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Mar 12, 2026 13:51 UTC